Skip to main content
    P

    Phio Pharmaceuticals Corp (PHIO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.75
    -0.02 (-2.44%)

    Market Cap: $9.21M

    Last updated: Nov 17, 2026 at 11:00 AM ET

    Phio Pharmaceuticals Corp (PHIO) Earnings: Report Dates and Results

    Updated Nov 5, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Phio Pharmaceuticals (PHIO) is expected to report earnings on Mar 3, 2027. In the quarter ended Sep 30, 2026, Phio Pharmaceuticals reported EPS of -$0.36, in line with the -$0.36 estimate. It beat the EPS estimate in 3 of the 8 most recent quarters that had an estimate.

    Earnings

    Performance (10Y)

    Beat Rate
    53%(18/34)
    Avg Surprise
    +0.14%

    Upcoming Estimates

    Reports Mar 3, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.39
    Range-$0.39 - -$0.39
    4 analysts
    Revenue Consensus
    N/A
    RangeN/A
    4 analysts
    Reports May 5, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.13
    Range-$0.13 - -$0.13
    1 analysts
    EPS Revisions
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.20+35.0%
    60d ago-$0.130.0%
    30d ago-$0.130.0%
    7d ago-$0.130.0%
    Current-$0.13
    Revenue Consensus
    N/A
    RangeN/A
    1 analysts

    Next Report

    PHIO has an expected report date of Mar 3, 2027.

    Earnings History

    Of the 34 quarters below that had an estimate, PHIO beat 18, missed 10 and matched 6. The widest gap in the table came in the quarter ended Sep 30, 2022, when EPS landed 172.22% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.36-$0.36-$0.37 - -$0.350.00%In lineN/A20 up, 2 downNov 5, 2026N/A
    Jun 30, 2026-$0.36-$0.36-$0.37 - -$0.350.00%In lineN/A20 up, 2 downAug 6, 2026N/A
    Mar 31, 2026-$0.34-$0.23-$0.24 - -$0.23-47.83%MissN/A21 up, 0 downMay 7, 2026N/A
    Dec 31, 2025-$0.15-$0.47-$0.47 - -$0.47+68.09%BeatN/A10 up, 0 downMar 5, 2026N/A
    Sep 30, 2025-$0.44-$0.44-$0.44 - -$0.440.00%In lineN/A10 up, 0 downNov 13, 2025N/A
    Jun 30, 2025-$0.45-$0.36N/A-25.00%MissN/AN/A0 up, 0 downAug 14, 2025N/A
    Mar 31, 2025-$0.41N/AN/AN/AN/AN/AN/A0 up, 0 downMay 15, 2025N/A
    Dec 31, 2024-$0.85-$1.23N/A+30.89%BeatN/AN/A0 up, 0 downMar 31, 2025$70000
    Sep 30, 2024-$1.54-$4.14N/A+62.80%BeatN/AN/A0 up, 0 downNov 14, 2024N/A
    Jun 30, 2024-$3.62-$4.59-$4.59 - -$4.59+21.13%BeatN/A10 up, 0 downAug 14, 2024N/A
    Mar 31, 2024-$1.53-$1.30N/A-17.70%MissN/AN/A0 up, 0 downApr 1, 2024N/A
    Dec 31, 2023-$0.85-$1.30-$1.30 - -$1.30+34.62%BeatN/A10 up, 0 downMar 20, 2024$6000
    Sep 30, 2023-$10.26-$12.87N/A+20.28%BeatN/AN/AN/ANov 9, 2023N/A
    Jun 30, 2023-$1.47N/AN/AN/AN/AN/AN/A0 up, 0 downAug 10, 2023N/A
    Mar 31, 2023-$3.15N/AN/AN/AN/AN/AN/A0 up, 0 downMay 11, 2023N/A
    Dec 31, 2022-$21.78-$29.16N/A+25.31%BeatN/A10 up, 0 downMar 22, 2023N/A
    Sep 30, 2022-$28.08$38.88N/A-172.22%MissN/A10 up, 0 downNov 10, 2022N/A
    Jun 30, 2022-$20.52-$33.48N/A+38.71%BeatN/AN/A0 up, 0 downAug 11, 2022N/A
    Mar 31, 2022-$20.52-$32.40N/A+36.67%BeatN/A10 up, 0 downMay 12, 2022N/A
    Dec 31, 2021-$3.24-$3.84-$3.84 - -$3.84+15.63%BeatN/A1N/AMar 22, 2022N/A
    Sep 30, 2021-$30.24-$27.00N/A-12.00%MissN/A10 up, 0 downNov 10, 2021N/A
    Jun 30, 2021-$21.60-$28.08N/A+23.08%BeatN/A1N/AAug 12, 2021N/A
    Mar 31, 2021-$0.32N/AN/AN/AN/AN/AN/AN/AMay 13, 2021N/A
    Dec 31, 2020-$44.28-$45.36N/A+2.38%BeatN/AN/AN/AMar 25, 2021N/A
    Sep 30, 2020-$43.20-$40.50-$48.62 - -$32.42-6.67%MissN/A2N/ANov 10, 2020N/A
    Jun 30, 2020-$36.72-$69.66N/A+47.29%BeatN/AN/AN/AAug 12, 2020N/A
    Mar 31, 2020-$1.33N/AN/AN/AN/AN/AN/AN/AMay 12, 2020N/A
    Dec 31, 2019-$543.24-$475.20N/A-14.32%MissN/AN/AN/AMar 26, 2020N/A
    Sep 30, 2019-$475.20-$475.20N/A0.00%In lineN/A1N/ANov 12, 2019N/A
    Jun 30, 2019-$475.20-$475.20N/A0.00%In lineN/A1N/AAug 12, 2019N/A
    Mar 31, 2019-$594.00-$475.20N/A-25.00%MissN/AN/AN/AMay 14, 2019$21000
    Dec 31, 2018-$66.00-$72.60N/A+9.09%BeatN/AN/AN/AMar 27, 2019$81000
    Sep 30, 2018-$2,019.60-$2,643.30N/A+23.60%BeatN/AN/AN/ANov 14, 2018$57000
    Jun 30, 2018-$2,732.40-$3,504.61N/A+22.03%BeatN/AN/AN/AAug 14, 2018$58000
    Mar 31, 2018-$49.23N/AN/AN/AN/AN/AN/AN/AMay 10, 2018$23000
    Dec 31, 2017-$4,989.61-$5,702.41N/A+12.50%BeatN/AN/AN/AMar 26, 2018$15000
    Sep 30, 2017-$6,534.01-$6,534.01N/A0.00%In lineN/AN/AN/ANov 8, 2017N/A
    Jun 30, 2017-$6,444.91-$6,534.01N/A+1.36%BeatN/AN/AN/AAug 10, 2017N/A
    Mar 31, 2017-$7,128.01-$6,534.01N/A-9.09%MissN/AN/AN/AMay 11, 2017N/A
    Dec 31, 2016-$3,960.00-$1,518.00N/A-160.87%MissN/AN/AN/AMar 30, 2017$19000
    Last 40 quarters

    Estimates made before a stock split are shown on the same share basis as the reported EPS.

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$1.45, after -$7.54 the year before. It was -$46,596.06 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$1.45N/A
    Dec 31, 2024-$7.54N/A
    Dec 31, 2023-$15.74N/A
    Dec 31, 2022-$90.90N/A
    Dec 31, 2021-$55.40N/A
    Dec 31, 2020-$125.53N/A
    Dec 31, 2019-$2,087.64N/A
    Dec 31, 2018-$4,867.23N/A
    Dec 31, 2017-$25,096.54N/A
    Dec 31, 2016-$46,596.06N/A

    Frequently Asked Questions About PHIO

    When is Phio Pharmaceuticals's next earnings date?

    Phio Pharmaceuticals's next earnings report is expected for Mar 3, 2027.

    Did PHIO beat earnings estimates last quarter?

    Phio Pharmaceuticals reported EPS of -$0.36 for the quarter ended Sep 30, 2026, in line with the -$0.36 estimate.

    What EPS do analysts expect from PHIO next quarter?

    The consensus EPS estimate for Phio Pharmaceuticals for the quarter ending Dec 31, 2026 is -$0.39 from 4 analysts, with estimates from -$0.39 to -$0.39.

    How often does PHIO beat earnings estimates?

    Phio Pharmaceuticals beat the EPS estimate in 3 of the 8 most recent quarters that had an estimate, with an average surprise of +11.12%.